151 related articles for article (PubMed ID: 9651473)
1. Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene.
Huber R; Schlessinger D; Pilia G
Gene; 1998 Jul; 214(1-2):35-44. PubMed ID: 9651473
[TBL] [Abstract][Full Text] [Related]
2. Glypican 3 and glypican 4 are juxtaposed in Xq26.1.
Huber R; Mazzarella R; Chen CN; Chen E; Ireland M; Lindsay S; Pilia G; Crisponi L
Gene; 1998 Dec; 225(1-2):9-16. PubMed ID: 9931407
[TBL] [Abstract][Full Text] [Related]
3. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
[TBL] [Abstract][Full Text] [Related]
4. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
5. A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome.
Okamoto N; Yagi M; Imura K; Wada Y
J Hum Genet; 1999; 44(5):327-9. PubMed ID: 10496077
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G
Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714
[TBL] [Abstract][Full Text] [Related]
7. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
Cano-Gauci DF; Song HH; Yang H; McKerlie C; Choo B; Shi W; Pullano R; Piscione TD; Grisaru S; Soon S; Sedlackova L; Tanswell AK; Mak TW; Yeger H; Lockwood GA; Rosenblum ND; Filmus J
J Cell Biol; 1999 Jul; 146(1):255-64. PubMed ID: 10402475
[TBL] [Abstract][Full Text] [Related]
8. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
Xuan JY; Hughes-Benzie RM; MacKenzie AE
J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
[TBL] [Abstract][Full Text] [Related]
9. Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene.
Huber R; Crisponi L; Mazzarella R; Chen CN; Su Y; Shizuya H; Chen EY; Cao A; Pilia G
Genomics; 1997 Oct; 45(1):48-58. PubMed ID: 9339360
[TBL] [Abstract][Full Text] [Related]
10. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.
Li M; Shuman C; Fei YL; Cutiongco E; Bender HA; Stevens C; Wilkins-Haug L; Day-Salvatore D; Yong SL; Geraghty MT; Squire J; Weksberg R
Am J Med Genet; 2001 Aug; 102(2):161-8. PubMed ID: 11477610
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for basal expression of rat mitochondrial branched-chain-2-oxo-acid dehydrogenase kinase [corrected].
Huang YS; Chuang DT
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):713-22. PubMed ID: 9729481
[TBL] [Abstract][Full Text] [Related]
12. Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome.
Lindsay S; Ireland M; O'Brien O; Clayton-Smith J; Hurst JA; Mann J; Cole T; Sampson J; Slaney S; Schlessinger D; Burn J; Pilia G
J Med Genet; 1997 Jun; 34(6):480-3. PubMed ID: 9192268
[TBL] [Abstract][Full Text] [Related]
13. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
Lin H; Huber R; Schlessinger D; Morin PJ
Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
[TBL] [Abstract][Full Text] [Related]
14. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
Murthy SS; Shen T; De Rienzo A; Lee WC; Ferriola PC; Jhanwar SC; Mossman BT; Filmus J; Testa JR
Oncogene; 2000 Jan; 19(3):410-6. PubMed ID: 10656689
[TBL] [Abstract][Full Text] [Related]
15. Protein interactions at Sp1-like sites in the TGF alpha promoter as visualized by in vivo genomic footprinting.
Chen X; Wright KL; Berkowitz EA; Azizkhan JC; Ting JP; Lee DC
Oncogene; 1994 Nov; 9(11):3179-87. PubMed ID: 7936640
[TBL] [Abstract][Full Text] [Related]
16. Sp1 and Sp3 transactivate the RET proto-oncogene promoter.
Andrew SD; Delhanty PJ; Mulligan LM; Robinson BG
Gene; 2000 Oct; 256(1-2):283-91. PubMed ID: 11054558
[TBL] [Abstract][Full Text] [Related]
17. Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome.
Pellegrini M; Pilia G; Pantano S; Lucchini F; Uda M; Fumi M; Cao A; Schlessinger D; Forabosco A
Dev Dyn; 1998 Dec; 213(4):431-9. PubMed ID: 9853964
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization.
Shen T; Sonoda G; Hamid J; Li M; Filmus J; Buick RN; Testa JR
Mamm Genome; 1997 Jan; 8(1):72. PubMed ID: 9021160
[No Abstract] [Full Text] [Related]
19. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13.
Paine-Saunders S; Viviano BL; Saunders S
Genomics; 1999 May; 57(3):455-8. PubMed ID: 10329016
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation in transcriptional repression of two differentially expressed X-linked genes, GPC3 and SYBL1.
Huber R; Hansen RS; Strazzullo M; Pengue G; Mazzarella R; D'Urso M; Schlessinger D; Pilia G; Gartler SM; D'Esposito M
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):616-21. PubMed ID: 9892682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
